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University, Aydın, and 4Radiology, Faculty of Medicine, Ege University, Izmir, TurkeyWe report a case of an immuno-suppressed 49-year-old man with mycotic aneurysm of left subclavian artery. The aneurysm
was diagnosed by computed tomography and digital subtraction angiography. Our choice for treatment was endovascular
stent-graft implantation. After stent-graft implantation, type I endoleak was present because of the aneurysm had broad neck
and, so, we implanted second stent-graft proximally to the first stent. The end of the procedure, there was a minimal type III
endoleak into the aneurysm sac. The patient was well and free of symptoms after 1 week. A control CT angiography, after 5
months, showed a completely thrombosed aneurysm without an endoleak. Endovascular repair of a mycotic subclavian
artery aneurysm may be an alternative to open surgery.Keywords: Mycotic aneurysm; Subclavian artery; Stent-graft; Endovascular; CT angiography.Introduction
The subclavian artery is unusual site for mycotic
aneurysm.1 The aneurysm must be repaired promptly
because of the risks of complications. Although the
conventional treatment of subclavian artery aneurysm
is open surgery. Open surgical procedure may require
throracotomy or a transsternal approach to treat an
aneurysm extending beyond the thoracic inlet. Endo-
vascular stent-graft implantation may, therefore, be a
good minimal invasive alternative. Endovascular
approach eliminates the need for surgical dissection,
decreasing the risk for injuring important adjacent
structures such as the vagus nerve, recurrent laryngeal
nerve, and phrenic nerve, and the innominate vein.
Additionally, surgical treatment of mycotic aneurysm
has a risk for sepsis, which can be seen in up to 80% in
of urgent operations. Therefore, endovascular therapy
of an infected aneurysm could be good treatment
choice in urgent cases. In the literature, a few articles
about endovascular treatment of subclavian arterying author. Dr Kutsi Koseoglu, Associate Professor,
of Radiology, Faculty of Medicine, Adnan Menderes
100 Aydın, Turkey.
: kutsikoseoglu@yahoo.com
2006 Elsevier Ltd. Open access under CC BY-NC-ND license.aneurysms have been reported.2,3 We found one
publication about endovascular treatment of a mycotic
subclavian artery aneurysm.4
We present an endovascular stent-graft treatment
for a mycotic subclavian artery aneurysm.Case Report
A 49-year-old man was admitted to hospital with pain,
paresthesia and coldness of left forearm, ptosis of left
eyelid and a fever. He had a history of uncontrolled
type II diabetes mellitus for 11 years. He also under-
went left supraclavicular lymph node biopsy 4 months
earlier. This biopsy was not thought to be the cause of
aneurysm because the biopsy site was not close to the
aneurysm. On examination, we found crepitus and
tenderness over the sternum, paresthesia and weak-
ness left hand and forearm, and miosis and ptosis of
left eye. He had a body temperature 39 8C. Blood
cultures were negative. Laboratory tests showed a
white blood cell count of 12,800/ml and a C-reactive
protein level of 54 mg/l. The erythrocyte sedimen-
tation was 57 mm/h and fasting plasma glucose wasEJVES Extra 11, 97–101 (2006)
doi:10.1016/j.ejvsextra.2006.02.002, available online at http://www.sciencedirect.com on
Fig. 1. There are seen several CT section of upper thorax. A thick walled aneurysm (arrow) of left subclavian artery is seen on
contrast enhanced CT. A cavitary lesion (arrow head) adjacent to aneurysm in the anterior lobe of left lung and anterior
thorax wall is seen on level of aortic arc on CT images.
K. Koseoglu et al.98184 mg/dl. Electromyography demonstrated brachial
plexus damage on the left side.
The posterior–anterior and lateral chest X-ray a
showed wide left upper mediastinum in relation to a
vascular abnormality in the supra-aortic trunks and a
retrosternal soft tissue mass adjacent to sternum.
Computed tomography (CT) of the chest revealed a
large left sided subclavian artery aneurysm measuring
4.2 cm in diameter and abscess formation adjacent to
sternum and left rib (Fig. 1). Three-dimensional CT
angiography (3D-CTA) confirmed an aneurysm in
middle third of the left subclavian artery without any
sign of rupture. There were two nipple-shaped blebs
on the superior border of the aneurysm. SelectiveFig. 2. (A) CT angiography demonstrated a broad necked an
subclavian artery catheter angiography clearly showed the par
left vertebral artery (arrow head).
EJVES Extra Vol 11, May 2006angiography of the left subclavian artery demon-
strated that the aneurysm had a broad neck. The other
arteries of the aortic arch were normal (Fig. 2). A bone
scan showed an ostomyelitis of the manibrium sterni
and the anterior parts of the adjacent ribs on the left.
We thought that the aneurysm was mycotic, because of
the patient was immuno-compromised and had
infectious changes around the aneurysm. Broad-
spectrum antibiotics were given to the patient. After
3 days, body temperature was normal and we planned
to treat the aneurysm by endovascular approach.
The right femoral artery was cannulated with a
Seldinger technique after local anesthesia. An 11 F
introducer was placed into right femoral artery ineurysm (arrow) of left subclavian artery. (B) Selective left
ent artery and the aneurysm (arrow). There is also seen thin
Fig. 3. (A) Native angiographic image of stent-grafts after balloon angioplasty shows the patency of parent artery and
minimal filling due to endoleak (arrowhead) into the aneurysm sac. (B) Subtracted image clearly shows the type III endoleak
(arrow).
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introducer was placed into left femoral artery in order
to control the stent-graft position. An exchange—
length glide wire was advanced through a diagnostic
catheter to the distal end of the aneurysm. This wire
was then exchanged with 0.035 in. Amplatz stiff wire.
At the same time, 5000 IU heparin was given. After
that, a 10!70 mm covered stent (Wallgraft, Boston-
Scientific) was deployed in the aneurysm. A 9 mm
balloon was inflated to seal the stent at the proximal
neck of the aneurysm. Control angiography showed
proximal endoleak into aneurysm sac (type I endo-
leak). So, we implanted a second 10!50 mm covered
stent, which was positioned proximally to the
previous stent. At the end of the procedure, there
was a minimal endoleak (type III endoleak) at the site
of stent conjunction (Fig. 3). The procedure was ended
and anti-platelet treatment was given. A Doppler US
after 1 day confirmed a persistent minimal endoleakFig. 4. One day after, Doppler US of left subclavian artery shows
is also seen thrombosed aneusym sac (arrow head).into the aneurysm, but a control Doppler US a week
later showed diminishing of the endoleak (Fig. 4). The
Horner syndrome disappeared 1 week later and the
patient became symptom free. We planned a follow up
CT angiography after 6 and 12 months to check for
distal ischemia or re-aneurysm formation. In case of
stent-graft infection, surgical intervention and homo-
graft interposition could be a good treatment choice.
After 5 months from stent-graft implantation,
control CT angiography demonstrated that the aneur-
ysm of subclavian artery was totally thrombosed and
there was no endoleak into the aneurysm (Fig. 5). The
lumen of stent-graft was patent.Discussion
The incidence of true subclavian artery aneurysms
(SAA) is rare; it is only 0.13% of all aneurysms.1 Thethe endoleak (arrow) arising from a hole of stent-graft. There
EJVES Extra Vol 11, May 2006
Fig. 5. Five months after the endovascular treatment, CT images (A) and CT angiography (B) show that there is no filling into
aneurysm sac (arrow) and the parent artery is patent.
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formation in the subclavian arteries are atherosclero-
sis, thoracic outlet compression syndrome, trauma;
less common factors are cystic medial necrosis,
pulmonary tuberculosis, syphilitic arteritis, Marfan
syndrome, Turner’s disease, Behc¸et’s disease, aortitis
syndrome and congenital arterial disease.5,6 Right-
sided aneurysms are more common, the male to
female ratio is 2:1 and the mean age is 49 years.6
Mycotic (infectious) aneurysms may be caused by
direct invasion of vessel wall from an adjacent
infection via the vasa vasorum. Mycotic aneurysms
of SAA are extremely rare and the prognosis of
patients with mycotic aneurysms appears to be
substantially worse than uninfected aneurysms.7
Etiologic factors of mycotic aneurysm include drug
abuse, alcohol, endocarditis, septicemia, immuno-
compromised state, and poorly controlled soft-tissue
infection.8 The most common organisms are Staphylo-
coccus aureus and Salmonella species. Positive blood
culture is found in 50–70% of patients.9
The aneurysm of the proximal part of subclavian
artery may be asymptomatic for a long time, but they
may cause dysphagia or dyspnea. Peripheral embo-
lism of the upper limb is the most frequent clinical
manifestation of an aneurysm situated in the middle
and distal part of the subclavian artery. The aneurysm
can compress the subclavian vein and lead to arm
edema. Neurological symptoms from the pressure of
the aneurysm to the brachial plexus may cause
dysaesthesias in the ulnar nerve area and Raynaud’s
phenomenon.5
The diagnosis can be made by Doppler US,
angiography, CT and MRI. Angiography is mandatory
for planning of the treatment of an extrathoracic SAA.
In cases of intrathoracic aneurysms, CT and MRI scansEJVES Extra Vol 11, May 2006are necessary. Actual nature of aneurysm is better
defined by angiography. Perivascular soft tissue can be
examined by CT and MRI.10,11
Almost all subclavian artery aneurysms should be
repaired because of the complication risk. The
conventional treatment of subclavian artery aneurysm
is surgery. Surgery involves repair of the aneurysm
with a vein or synthetic graft material. A number of
surgical approaches, including clavicular resection,
median sternotomy and thoracotomy have been
advocated, but each carries its own risks and
complications. The complication risk of surgery is
related to experience and skill of the surgeon, hospital
expertise and the basic underlying health of the
patient.11
Interventional endovascular techniques such as stent-
graft implantation have been introduced for aortic and
peripheral artery aneurysms. The endoleaks are com-
mon encountered problems in the endovascular treat-
ment of aneurysms. There are several types of endoleak.
Type I endoleaks are caused by incomplete sealing of the
stent-graft in the proximal or distal implantation zones.
These types endoleaks are usually treated with exten-
sion of stent-graft by adding second stent or stent-
graft.12,13 Type III endoleaks may occur due to graft
related factors such as graft component disconnection or
fabric tears or disintegration. In our case, we overcame
the type I endoleak with extending the stent-graft. Also,
minimal type III endoleak, which was noticed after
balloon dilatation, settled spontaneously.
In conclusion, surgical intervention in the subcla-
vian artery aneurysmal disease is not without serious
risks. Our case showed that the endovascular exclu-
sion of a mycotic subclavian aneurysms aneurysm
with a stent-graft could be an successful treatment
alternative.
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